Photo of Alyson Tocicki

Alyson Tocicki is an associate in the Litigation Department and a member of the Trials Practice Group. Alyson handles high-profile and complex litigation matters around the country, with a particular emphasis on product liability, false advertising, and intellectual property disputes.

Alyson has experience representing clients at all stages of litigation, including: filing initial pleadings; coordinating discovery; briefing and arguing motions; assisting with key fact and expert witness depositions; writing jury addresses; drafting direct and cross examinations; and preparing witnesses for trial. She regularly represents Fortune 500 companies in the media and entertainment, consumer products, and pharmaceutical industries, as well as professional sports leagues and teams. Alyson leverages her experience to provide creative solutions and to manage her cases with an eye towards trial.

In addition, Alyson devotes significant time to pro bono matters, having been recognized at Proskauer’s 2023 Golden Gavel Awards for her substantial contributions to the Firm’s pro bono efforts. She also serves as a member of the Firm’s Associate Council and was selected to be a Protégée for Proskauer’s Women’s Sponsorship Program, an initiative for high-performing, mid-level lawyers that champions future leaders.

Prior to joining Proskauer, Alyson earned her J.D. from the UCLA School of Law, where she served as a Managing Editor of the UCLA Law Review and President of the Student Bar Association. While in law school, she also earned multiple Masin Family Academic Excellence Awards, advised first-year students on legal research and writing, and worked as a judicial extern for the Honorable Robert N. Kwan in the United States Bankruptcy Court for the Central District of California.

In the rapidly evolving biotech and life sciences sectors, the importance of trade secrets has grown significantly. Companies are investing heavily in research and development to create cutting-edge treatment therapies. Protecting proprietary methodologies and innovations is crucial for maintaining competitive advantage and fostering innovation. Moreover, the rise of artificial intelligence

Proving access to and use of trade secrets are core elements in a trade secrets misappropriation case.  Recent rulings in a trade secrets action filed by Allergan against its competitor Revance Therapeutics (“Revance”) provide helpful guidance on what is sufficient to plead these elements. There, the court explained what facts are—and